ORPHELIA Pharma
Laurent Martin serves as the Chief Pharmaceutical Affairs Officer and Pharmacien Responsable at ORPHELIA Pharma since January 2020. Prior to this role, Laurent held various senior positions at DBV Technologies from July 2007 to January 2020, including Chief Pharmaceutical Officer, Chief Development Officer, and Senior Vice President of Product Strategy & Regulatory Affairs. Laurent's early career includes significant roles at Orphan Europe and Guerbet, with responsibilities in drug development and international registration management. Laurent's academic background includes a Master in Business Administration from IAE Paris - Sorbonne Business School, a Master in Public Health Law from Law School in Sceaux, France, and a PharmD. from Université Paris Cité.
This person is not in the org chart
This person is not in any teams
ORPHELIA Pharma
ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.